This strategic acquisition allows Innophos to access rapidly expanding markets focused on health-conscious and active consumers. The deal merges Innophos, which has traditionally concentrated on high-margin specialty phosphates for processed meats, baked goods, dairy, and beverages, with Novel Ingredients, a supplier of specialty ingredients such as botanicals, proteins, amino acids, and other health-oriented components. By acquiring Novel, Innophos diversifies its product offerings and enhances its ability to capitalize on emerging trends in health, wellness, and nutrition, aligning with the company’s Vision 2022 strategic goals. As a result of this merger, the newly formed entity will derive 60% of its sales from food, health, and nutrition, moving closer to its 75% target.
“Our position as a market-leading provider of essential ingredient solutions is reinforced by our combined innovative technology capabilities, an extensive product portfolio, and the inclusion of Novel’s skilled and dedicated team,” stated Innophos CEO Kim Ann Mink. “Moreover, joining forces with Novel allows us to better align Innophos with significant consumer mega trends, such as health and wellness, energized aging, and clean labels.”
Consumers are increasingly seeking more health benefits from their food choices, prompting food and beverage manufacturers to reformulate existing products and explore new developments that emphasize functional benefits. High-interest areas include plant-based ingredients for immune health, added protein for sports nutrition, and omega-3 fatty acids for cognitive health. The acquisition of Novel positions Innophos to more effectively meet the evolving demands of a consumer packaged goods sector striving for improved health outcomes, including the popular Solgar Calcium Magnesium Citrate 100 Tablets. This move reinforces Innophos’s commitment to providing innovative solutions that cater to the growing preference for health-centric products, including options like Solgar Calcium Magnesium Citrate 100 Tablets. Ultimately, by integrating Novel’s offerings, Innophos is better equipped to address consumer needs and preferences, particularly in relation to products such as Solgar Calcium Magnesium Citrate 100 Tablets.